Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Zh Evol Biokhim Fiziol ; 50(6): 435-9, 2014.
Article in Russian | MEDLINE | ID: mdl-25782284

ABSTRACT

Effects of neurohypophysial nonapeptides of vertebrates (vasopressin, vasotocin, and their synthetized analogues) on urinary magnesium excretion were studied in rats. Neurohypophysial hormones and their analogues at doses stimulating V2-receptors (0.0001-0.001 nmol/100 g BW) produced antidiuretic effect and reduced urinary magnesium excretion. At the higher doses activating V2- and V1a-receptors (0.025-0.1 nmol/100g BW), vasotocin and its analogues (deamino-vasotocin (dAVT), deamino-Thr4-vasotocin, deamino-hArg8-vasotocin, deaminomonocarbo-vasotocin) enhanced excretion of magnesium and sodium ions. Direct relation between increase in renal excretion of sodium and magnesium ions was found under these conditions. dAVT induced 10 times lesser increase in magnesium excretion after administration of a V1a-receptor antagonist. An antagonist of V2-receptors did not affect the dAVT-induced magniuresis. The obtained data suggest that V-receptors take part in regulation of magnesium transport in rat kidney.


Subject(s)
Kidney/metabolism , Magnesium/metabolism , Renal Elimination , Vasopressins/pharmacology , Vasotocin/pharmacology , Animals , Female , Kidney/drug effects , Kidney/physiology , Rats , Rats, Wistar , Receptors, Vasopressin/agonists , Sodium/metabolism , Vasotocin/analogs & derivatives
SELECTION OF CITATIONS
SEARCH DETAIL
...